|
|
Drugs for Hepadnavirus Infection (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 198)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Lamivudine | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 594 | 134678-17-4 | 60825 | (+/-) (Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (+/-)-3TC (+/-)-BCH-189 (+/-)-SddC (-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine (-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine (-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (-)-2'-Deoxy-3'-thiacytidine (-)-BCH 189 (-)-BCH-189 (-)-SddC (-)-beta-L-2',3'-Dideoxy-3'-thiacytidine (-)NGPB-21 (2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one .beta.-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To 134678-17-4 2',3' Dideoxy 3' thiacytidine 2',3'-Dideoxy-3'-thiacytidine 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-) (Cis) 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Galanthus Nivalis Agglutinin (GNA) 2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Hippeastrum hybrid agglutinin( HHA) 3'-Thia-2',3'-dideoxycytidine 3-TC 3TC 3TC & GNA 3TC & SST 3TC (AIDS INITIATIVE) (AIDS INITIATIVE) 3TC and NV-01 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine 4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one 480434-79-5 AC-1416 AC1L1TZZ AC1Q6C34 BCH 189 BCH-189 BCH-790 BCH189 BIDD:GT0033 Bio-0652 C07065 C8H11N3O3S CCRIS 9274 CHEBI:133986 CHEMBL141 CID60825 CPD000466319 D00353 D019259 DB00709 | DRG-0126 DTHC Epivir Epivir (TN) Epivir HBV Epivir(TM) Epivir-HBV Epzicom FT-0082667 GG-714 GR 109714 X GR 109714X GR-109714X GR109714X HHA & 3TC HHA & Lamivudine HMS2051D21 HSDB 7155 Hepitec Heptivir Heptodin Heptovir L0217 LMV LS-2107 Lamivir Lamivudin Lamivudina Lamivudine Lamivudine & GNA Lamivudine (JAN/USP/INN) Lamivudine [USAN:BAN:INN] Lamivudine [USAN:INN:BAN] Lamivudine [Usan:Ban:Inn] Lamivudine, (2S-cis)-Isomer Lamivudinum MLS000759424 MLS001424097 MolPort-002-507-347 NCGC00159341-03 NCGC00159341-04 NSC620753 S1706_Selleck SAM001246582 SAM002589994 SMR000466319 STK801940 UNII-2T8Q726O95 ZINC00012346 Zeffix Zefix beta-L-2',3'-Dideoxy-3'-thiacytidine beta-L-3'-Thia-2',3'-dideoxycytidine lamivudine | |
| | 2 | | Adefovir Dipivoxil | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 130 | 142340-99-6 | 60871 | (((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis(oxymethylene) 2,2-dimethylpropanoate ((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid, diester with hydroxymethyl pivalate 142340-99-6 9-(2-((-Bis((pivaloyloxy)methoxy)phosphinyl)methoxy)ethyl)adenine 9-(2-((Bis((pivaloyloxy)methoxy)phosphinyl)methoxy)ethyl)adenine AC-1693 AC1L1U36 ADEFOVIR DIPIVOXIL ADV AKOS005145737 Adefovir Adefovir Dipivoxil Adefovir Pivoxil Adefovir dipivoxil Adefovir dipivoxil (USAN) Adefovir pivoxil Adefovir pivoxil (JAN) Adefovirdipivoxl Adefovirum Adéfovir Ambap142340-99-6 Bis(POM)-PMEA Bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine Bis(pom)PMEA Bis-POM PMEA Bis-POM PMEA, Adefovir Dipivoxil Bis-POM PMEA, Preveon, Hepsera, Adefovir Dipivoxil C20H32N5O8P CHEMBL922 | CID60871 D01655 DB00718 FT-0082875 GS 0840 GS 840 GS-0840 GS-840 HePSera Hepsera Hepsera (TM) Hepsera (TN) I06-1150 I14-3234 LS-173141 MolPort-003-986-417 NCGC00164624-01 PMEA Piv2PMEA Preveon Propanoic acid, 2,2-dimethyl-, (((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis(oxymethylene) ester Propanoic acid,2,2-dimethyl-(((2-(6-amino-9H-purin-9-yl)ehtoxy)mehtyl)phosphinyldiene)bis(oxymehtylene)ester S1718_Selleck TL8000938 UNII-U6Q8Z01514 YouHeDing ZINC03930376 [2-(6-aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate adefovir depivoxil bis-POM PMEA | |
| | 3 | | Peginterferon alfa-2b | approved | Phase 4, Phase 3, Phase 2 | 299 | 99210-65-8 | | 215647-85-1 D02748 PEG-Intron PegIntron Peginterferon alfa-2b | Peginterferon alfa-2b (INN) Peginterferon alfa-2b (generical recombination) Peginterferon alfa-2b (generical recombination) (JAN) Pegintron Pegintron (TN) Sylatron Unitron PEG |
| | 4 | | Peginterferon alfa-2a | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 537 | 198153-51-4 | 5360545 | | Pegasys (TN) Peginterferon alfa-2a Peginterferon alfa-2a (USAN/INN) Peginterferon alfa-2a (genetical recombination) Peginterferon alfa-2a (genetical recombination) (JAN) |
| | 5 | | rituximab | approved | Phase 4, Phase 3 | 1582 | 174722-31-7 | 10201696 | AntiCD20 IDEC-102 IDEC-C2B8 | Ig gamma-1 chain C region MabThera Mabthera Rituxan rituximab |
| | 6 | | Ritonavir | approved, investigational | Phase 4, Phase 2, Phase 3 | 850 | 155213-67-5 | 392622 | 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate 155213-67-5 1hxw 1sh9 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate 538, ABT A-84538 ABBOTT-84538 ABT 538 ABT 84538 ABT-538 ABT538 AC-733 AC1L94GB AKOS000280930 Abbott 84538 BIDD:GT0387 BIDD:PXR0023 Bio-0093 C07240 C37H48N6O5S2 CHEBI:45409 CHEMBL163 CID392622 CPD000466395 D00427 D019438 | DB00503 DRG-0244 FT-0082824 HMS2051B08 HSDB 7160 LS-148860 MLS000759541 MLS001424063 MolPort-000-883-877 N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide NCGC00159462-02 NSC693184 Norvir Norvir (TM) Norvir (TN) Norvir Sec RIT RTV Ritonavir Ritonavir (JAN/USAN/INN) Ritonavir [USAN] Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavirum S1185_Selleck SAM001246783 SMR000466395 STK634209 ZINC03944422 ritonavir | |
| | 7 | | Etravirine | approved | Phase 4 | 73 | 269055-15-4 | 193962 | 269055-15-4 394729-17-0 4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)-4-pyrimidinyl)oxy)-3,5-dimethyl-benzonitrile 4-({6-AMINO-5-BROMO-2-[(4-CYANOPHENYL)AMINO]PYRIMIDIN-4-YL}OXY)-3,5-DIMETHYLBENZONITRILE 4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile 65B AC1L4XC5 CHEBI:213138 CHEMBL308954 CID193962 D04112 DAPY deriv DB07191 Diaminopyrimidine deriv Etravirine | Etravirine (JAN/USAN/INN) I06-1887 Intelence Intelence (TN) Intelence(TM) R 165335 R-165335 R165335 R165335-TMC125 ST51053273 TMC 125 TMC-125 TMC-125/R-165335 TMC125 UNII-0C50HW4FO1 ZINC00602632 | |
| | 8 | | Aluminum hydroxide | approved | Phase 4, Phase 3, Phase 1 | 178 | | | | Aluminum Hydroxide Aluminum hydroxide Dermadrox | |
| | 9 | | Ethiodized oil | approved | Phase 4, Phase 2 | 82 | 8008-53-5 | | | | 10 | | Darunavir | approved | Phase 4 | 198 | 635728-49-3, 206361-99-1 | 213039 | (3-((4-aminobenzenesulfonyl)isobutylamino)-1-benzyl-2-hydroxypropyl)carbamic acid hexahydrofuro(2,3-b)furan-3-yl ester (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE (3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate (3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate (3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate (3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate (3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate (3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate 206361-99-1 2f80 2f81 2f8g 2hs1 2hs2 2idw 2ien 3bvb 3cyw 3d1z 3d20 618109-00-5 AC1L4U4V AIDS073035 CHEBI:367163 CHEMBL1323 | CID213039 Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester D03656 DB01264 Darunavir Darunavir (USAN/INN) Darunavir [USAN] Darunavirum Darunavirum [INN-Latin] Darunavirum [INN-latin] LS-187026 LS-187772 LS-191295 MolPort-003-846-141 N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide Prezista Prezista(TM) TMC 114 TMC-114 TMC114 UIC 94017 UIC-94017 UIC-96017 UNII-YO603Y8113 [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate [(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester [(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester {(1S,2R)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester {(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester | |
| | 11 | | Ribavirin | approved | Phase 4, Phase 3, Phase 2 | 948 | 36791-04-5 | 37542 | 1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide 1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide 36791-04-5 437710-49-1 66510-90-5 AA-504/07617051 AB00430481 AC1L1XXZ AC1Q1IDC AC1Q4ZGS AKOS001715163 BB_NC-0567 BPBio1_001195 BRN 0892462 BSPBio_001085 BSPBio_003352 C-Virin CHEMBL1643 CID37542 Copegus Copegus (TN) Cotronak D00423 DB00811 DRG-0028 DivK1c_000782 Drug: Ribavirin EU-0101063 FT-0082885 HMS2090L15 HMS2094O09 HMS502H04 HSDB 6513 ICN-1229 IDI1_000782 Ibavyr KBio1_000782 KBio2_002328 KBio2_004896 KBio2_007464 KBio3_002854 KBioGR_001804 KBioSS_002331 KS-1104 LS-1241 Lopac0_001063 MLS000028486 MLS002222317 Moderiba MolPort-002-507-104 MolPort-002-885-856 NCGC00090726-01 NCGC00090726-03 NCGC00090726-04 NCGC00090726-05 NCGC00090726-06 NCGC00090726-07 NINDS_000782 | NSC 163039 NSC163039 Prestwick3_000993 R 9644 R-964 R9644_SIGMA RBV RG-964 RIBAV RTC RTCA RTP Ravanex Rebetol Rebetol (TN) Rebetron Rebretron Ribacine Ribamide Ribamidil Ribamidyl Ribasphere Ribasphere (TN) Ribasphere Ribapak Ribav Ribavirin Ribavirin (JAN/USP/INN) Ribavirin Capsules Ribavirin Triphosphate Ribavirin [USAN:INN] Ribavirin-TP Ribavirina Ribavirina [INN-Spanish] Ribavirine Ribavirine [INN-French] Ribavirinum Ribavirinum [INN-Latin] Ribovirin Ro 20-9963/000 Ro-20-9963 S2504_Selleck SCH 18908 SMP1_000261 SMR000058315 SPECTRUM1503938 SR-01000076112-3 Spectrum3_001876 Spectrum4_001252 Spectrum5_002075 Spectrum_001826 Tribavirin UNII-49717AWG6K Varazid Vilona Viramid Viramide Virazid Virazide Virazole Virazole (Ribavirin) Inhalation Solution Virazole (TN) Virazole 5'-triphosphate ZINC01035331 ribavirin |
| | 12 | | Thymalfasin | approved, investigational | Phase 4, Phase 3, Phase 1, Phase 2 | 20 | 62304-98-7 | | | Thymosin alpha 1 Thymosin alpha1 Valopicitabine Zadaxin |
| | 13 | | Telbivudine | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 83 | 3424-98-4 | 159269 | 1-(2-Deoxy-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione 1-(2-Deoxy-beta-L-erythropentafuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione 1-(2-Deoxy-beta-L-ribofuranosyl)-5-methyluracil 1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione 2'-Deoxy-L-thymidine 3424-98-4 AC-5632 AC1L4LJI Beta-l-thymidine CHEBI:17748 CHEMBL374731 CID159269 D06675 DB01265 Epavudine I14-8810 L-DT L-Deoxythymidine L-Thymidine L-dT L-deoxythymidine L-thymidine | LDT LDT-600 LDT600 LLT LS-186402 LS-187347 LdT NB 02B NV 02B NV-02B S1651_Selleck Sebivo Telbivudin Telbivudine Telbivudine (USAN/INN) Telbivudine [USAN] Tyzeka Tyzeka (TN) Tyzeka, Sebivo, Telbivudine UNII-2OC4HKD3SF ZINC00002159 beta-L-2'-Deoxythymidine beta-L-Thymidine | |
| | 14 | | Maraviroc | approved, investigational | Phase 4 | 135 | 376348-65-1 | 3002977 | 376348-65-1 4,4-Difluoro-N-((1S)-3-(exo-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1)oct-8-yl)-1-phenylpropyl)cyclohexanecarboxamide 4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide 674782-29-7 AC-558 AC1MHEFQ CHEBI:537583 CHEMBL1201187 CHEMBL256907 CID3002977 Celsentri Celsentri(TM) DB04835 Isopropyl, 4,4-difluoro-N-((1S)-3-{(1R,3s,5S)-3-(3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1)octan-8-yl}-1-phenylpropyl)cyclohexanecarboxamide | LS-182818 MVC Maraviroc Maraviroc [USAN] PRO 140 & Maraviroc PRO 140 (Anti-CCR5 monoclonal antibody) & exo-4,4-Difluoro-N-[3-[3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1(S)-phenylpropyl]cyclohexanecarboxamide Selzentry Selzentry(TM) UK 427857 UK-427,857 UK-427,857 maraviroc (MVC) UK-427857 UNII-MD6P741W8A exo-4,4-Difluoro-N-[3-[3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1(S)-phenylpropyl]cyclohexanecarboxamide maraviroc | |
| | 15 | | Zidovudine | approved | Phase 4, Phase 2 | 491 | 30516-87-1 | 35370 | -Azido-3&prime -deoxythymidine 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine 3&prime 3' Azido 2',3' Dideoxythymidine 3' Azido 3' deoxythymidine 3'-Azido-2',3'-Dideoxythymidine 3'-Azido-3'-deoxythymidine 3'-Azido-3'-deoxythymidine & Concanavalin A 3'-Azido-3'-deoxythymidine & Erythropoietin 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19 3'-Azido-3'-deoxythymidine & Interleukin-1 3'-Azido-3'-deoxythymidine & Interleukin-2 3'-Azido-3'-deoxythymidine & Interleukin-6 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon 3'-Azido-3'-deoxythymidine & Sho-Saiko-To 3'-Azido-3'-deoxythymidine (AIDS) 3'-Azido-3'deoxythymidine & Interferon .alpha. 3'-Azidothymidine 3'-Deoxy-3'-azidothymidine 3'-azido-3'-deoxythymidine, AZT 3-Azido-3-deoxythymidine 30516-87-1 399024-19-2 A2169_SIGMA AC1L1TKL AC1Q2OEK AZT AZT & CD4(178)-PE 40 AZT & Colony-stimulating factor 2 AZT & Concanavalin A (ConA) AZT & EPO AZT & GM-CSF AZT & HPA AZT & IFN.alpha. AZT & IL-1 AZT & IL-2 AZT & IL-6 AZT & Interferon-.alpha.-2 AZT & Li & EPO AZT & Li & GM-CSF AZT & Li & IL-1 AZT & Li & IL-6 AZT & Lymphoblastoid Interferon AZT & NP (from PHCA or HSA) AZT & PM-19 AZT & SST AZT & rIFN.alpha.2 AZT & rsCD4 & rIFN.alpha.A AZT & rsT4 AZT & sCD4 AZT & srCD4 AZT (Antiviral) AZT Antiviral AZT TRANSPLACENTAL CARCINOGENESIS STUDY AZT+PRO 140 AZT, Antiviral Antiviral AZT Apo-Zidovudine Azidothymidine Aztec BB_NC-1012 BPBio1_000403 BRD-K72903603-001-04-6 BSPBio_000365 BSPBio_003153 BW A509U BW-A 509U BW-A-509U BW-A509U BWA 509U BWA-509U BWA509U C07210 CCRIS 105 CHEBI:10110 CHEBI:127307 CHEMBL129 CID35370 CPD000058351 | Compound S Cpd S D00413 D015215 DB00495 DRG-0004 DS-4152 & AZT DivK1c_000524 HMS1921J20 HMS2090G11 HMS2092D06 HMS501K06 HSDB 6515 IDI1_000524 Interferon AD + 3'-azido-3'-deoxythymidine Intron A & AZT K7 [P Ti2 W10 O40] KBio1_000524 KBio2_001828 KBio2_004396 KBio2_006964 KBio3_002653 KBioGR_000703 KBioSS_001828 LS-1159 Liposomal AZT-SN-1 Liposomal AZT-SN-3 MLS000028548 MLS001055351 MLS001076358 MLS002153202 MLS002222249 Met-SDF-1.beta. & AZT Met-SDF-1.beta. & Zidovudine MolPort-002-507-286 NCGC00023945-03 NCGC00023945-04 NCGC00023945-05 NCGC00023945-08 NCGC00178237-01 NCGC00178237-02 NINDS_000524 NSC 602670 Novo-Azt PC-SOD+AZT Prestwick3_000333 Propolis+AZT Racemic Liposomal AZT Retrovir Retrovir (TN) Retrovir(TM) SAM002548971 SMR000058351 SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle) SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle) SPBio_000834 SPECTRUM1502109 STK801891 Spectrum2_000927 Spectrum3_001507 Spectrum4_000332 Spectrum5_001101 Spectrum_001348 UNII-4B9XT59T7S ZDV ZIDOVUDINE [AZT] ZINC03779042 ZVD Zidovudin Zidovudina Zidovudina [Spanish] Zidovudine Zidovudine (JAN/USP/INN) Zidovudine EP III Zidovudine [USAN:INN:BAN:JAN] Zidovudine+PRO 140 Zidovudinum Zidovudinum [Latin] antiviral azidodeoxythymidine rIFN-beta seron & AZT racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle) zidovudin zidovudine | |
| | 16 | | Tenofovir | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 666 | 147127-20-6 | 464205 | (R)-9-(2-Phosphonomethoxypropyl)adenine (R)-9-(2-Phosphonylmethoxypropyl)adenine (R)-PMPA 147127-20-6 206184-49-8 AC-760 AC1LA9BO Anh. tenofovir Anhydrous tenofovir Apropovir CHEBI:45809 CHEMBL483 CID464205 D,L-Tenofovir DB00300 GNA & Tenofovir GS 1275 GS 1278 GS1278 HHA & Tenofovir | KS-5021 MolPort-003-850-411 NCGC00167535-01 PMPA PMPA-(R) Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Galanthus nivalis agglutinin (GNA) Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Hippeastrum hybrid agglutinin( HHA) Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- (9CI) Phosphonic acid, [[2-(6-amino-9H-purin-9 S1401_Selleck TDF TFV Tenefovir Tenofovir Tenofovir (anh.) Tenofovir Disoproxil Fumarate Tenofovir disoproxil Tenofovir disoproxil fumarate UNII-99YXE507IL Viread Viread, Tenofovir [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid |
| | 17 | | Emtricitabine | approved, investigational | Phase 4, Phase 2, Phase 3 | 394 | 143491-57-0 | 60877 | (-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (-)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (-)-.beta.-L-FTC (-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine (-)-2'-Deoxy-5-fluoro-3'-thiacytidine (-)-FTC (-)-beta-2',3'-Dideoxy-5-fluoro-3'-thiacytidine (-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine (-)-cis-4-amino-5-Fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one (-)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one (2R-cis)-4-Amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone (2R-cis)-4-amino-5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone .beta.-L-(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine 143491-54-7 143491-57-0 145213-48-5 2',3',5-FTC 2',3'-Dideoxy-5-fluoro-3'-thiacytidine 2'-Deoxy-5-fluoro-3'-oxa-4'-thiocytidine 2'-Deoxy-5-fluoro-3'-thiacytidine 2-FTC 3'-Thia-2'.3'-dideoxy-5-fluorocytidine 4-Amino-5-fluoro-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one 4-Amino-5-fluoro-1-[(2R,5S)-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone 4-amino-5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one 5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine 5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine 5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)[1,3]oxathiolan-5-yl]cytosine 524W91 AC1L1U3I AC1Q4KUB BW 1592 | BW 524W91 BW-524W91 BW524W91 C122114 C12599 C8H10FN3O3S CHEBI:31536 CHEMBL885 CID60877 Coviracil Coviracil(TM) D01199 DB00879 DRG-0208 Emtricitabin Emtricitabina Emtricitabine Emtricitabine (JAN/USAN/INN) Emtricitabinum Emtriva Emtriva (TN) Emtriva(TM) FT-0080009 HMS2089I05 HSDB 7337 LS-135838 LS-173184 NCGC00164564-01 RCV Racivir SBB066061 TL8000958 UNII-G70B4ETF4S ZINC03629271 beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine dOTFC emtricitabine |
| | 18 | | Efavirenz | approved, investigational | Phase 4 | 398 | 154598-52-4 | 64139 | (-)-6-CHLORO-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one (-)-Efavirenz (4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one (4S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one (4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one (S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-ben (S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one (S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one (S)-6-chloro-4-(Cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one (S)-6-chloro-4-Cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[D][1,3]oxazin-2-one 154598-52-4 1ikv 1ikw 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)- (9 6-chloro-4-(2-Cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[D][1,3]oxazin-2-one 6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one AC-19049 AC1L20IX BIDD:GT0383 C08088 C14H9ClF3NO2 CHEBI:119486 CHEMBL223228 CID64139 CPD000466351 D00896 DB00625 DB07709 DMP 266 DMP-266 EFV | EFZ Efavirenz Efavirenz (JAN/INN) Efavirenzum Eravirenz HMS2051J08 HMS2090N16 HSDB 7163 L 743726 L-741211 L-743,726 L-743725 L-743726 LS-173464 MLS000759465 MLS001424087 Met-SDF-1.beta. & Efavirenz Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz MolPort-003-983-924 NSC742403 SAM001246667 SBB066062 SMR000466351 Stocrin Strocin (TM) Sustiva Sustiva (TM) Sustiva (TN) UNII-JE6H2O27P8 ZINC02020233 efavirenz efavirenz, (S)-isomer zoxazin-2-one Éfavirenz |
| | 19 | | Entecavir | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 170 | 142217-69-4 | 153941 | 142217-69-4 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one--water (1/1) 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one 209216-23-9 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl] 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate AB1004838 AC-1593 AC1L4BEC BMS-200475 Baraclude Baraclude (TN) CHEBI:473990 CHEBI:59902 CHEMBL713 | CID153941 D04008 D07896 DB00442 ETV Entecavir Entecavir (INN) Entecavir (USAN) Entecavir hydrate Entecavir hydrate (JAN) Entecavirum FT-0083013 MolPort-005-942-963 S2128_Selleck SBB066120 SQ-34676 TL8000933 ZINC03802690 entecavir monohydrate |
| | 20 | | Methylprednisolone | approved | Phase 4 | 1082 | 83-43-2 | 6741 | (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one (6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione .DELTA.1-6.alpha.-Methylhydrocortisone 1-Dehydro-6alpha-methylhydrocortisone 1-dehydro-6alpha-Methylhydrocortisone 1-dehydro-6α-methylhydrocortisone 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 121673-01-6 4-08-00-03498 (Beilstein Handbook Reference) 46436_FLUKA 46436_RIEDEL 570-35-4 6 Methylprednisolone 6-Methylprednisolone 6-alpha-Methylprednisolone 6.alpha.-Methylprednisolone 6923-42-8 6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 6alpha-Methylprednisolone 6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 83-43-2 A-methapred AC1L1N7A Artisone-Wyeth Artisone-wyeth BPBio1_000174 BRD-K35240538-001-03-1 BRN 2340300 BSPBio_000158 Besonia Bio-0658 CHEBI:6888 CHEMBL650 CID6741 CPD000058330 D00407 D008775 DB00959 Depo-Medrol (acetate) Depo-medrol Dopomedrol EINECS 201-476-4 Esametone Firmacort HMS1568H20 HMS2090B13 HSDB 3127 LMST02030178 LS-118498 Lemod M0639_SIGMA M1665 MEPRDL MLS000028541 MLS001148159 MLS002207191 Medesone Medixon Medlone 21 | Medrate Medrol Medrol (TN) Medrol Adt Pak Medrol Dosepak Medrol adt pak Medrol dosepak Medrol, Solu-Medrol, Medrone, Methylprednisolone Medrone Mesopren Metastab Methyleneprednisolone Methylprednisolon Methylprednisolone Methylprednisolone (JP15/USP/INN) Methylprednisolone [USAN:INN:BAN:JAN] Methylprednisolone, 6-alpha Methylprednisolonum Methylprednisolonum [INN-Latin] Metilbetasone Metilprednisolona Metilprednisolona [INN-Spanish] Metilprednisolone Metilprednisolone [DCIT] Metilprednisolone [Dcit] Metipred Metrisone Metrocort Metysolon Moderin MolPort-002-528-554 NCGC00022735-03 NCI60_001657 NSC-19987 NSC19987 Nirypan Noretona Predni N Tablinen Prednol- L Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI) Prestwick0_000279 Prestwick1_000279 Prestwick2_000279 Prestwick3_000279 Prestwick_622 Promacortine Reactenol S1733_Selleck SAM002589984 SMR000058330 SPBio_002377 Sieropresol Solomet Solu-medrol Summicort Suprametil U 7532 UNII-X4W7ZR7023 Urbason Urbasone Wyacort ZINC03875560 delta(1)-6alpha-Methylhydrocortisone delta(sup 1)-6-alpha-Methylhydrocortisone methylprednisolone methylprenisolone | |
| | 21 | | Prednisolone | approved | Phase 4 | 1082 | 50-24-8 | 5755 | (11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione .DELTA.1-Cortisol .DELTA.1-Dehydrocortisol .DELTA.1-Dehydrohydrocortisone .DELTA.1-Hydrocortisone .delta.-Cortef .delta.-Stab 1,2-Dehydrohydrocortisone 1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione 1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol 1-Dehydrocortisol 1-Dehydrohydrocortisone 3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene 46656_FLUKA 46656_RIEDEL 50-24-8 58201-11-9 8056-11-9 AC-1773 AC1L1L2E Ak-Pred Ak-Tate Alphadrol Articulose-50 BPBio1_000164 BRD-K98039984-001-03-0 BRN 1354103 BSPBio_000148 Bio-0666 Bubbli-Pred C07369 CCRIS 980 CHEBI:8378 CHEMBL131 CID5755 CO-Hydeltra CPD000718761 Co-Hydeltra Codelcortone Cordrol Cortalone Cotogesic Cotolone D00472 D011239 DB00860 Decaprednil Decortin H Delcortol Delta F Delta(1)-dehydrohydrocortisone Delta-Cortef Delta-Cortef (TN) Delta-Ef-Cortelan Delta-Stab Delta-stab Deltacortenol Deltacortril Deltacortril Enteric Deltahydrocortisone Deltasolone Deltisilone Depo-Medrol Derpo PD Derpo Pd Dexa-Cortidelt Hostacortin H Dexa-Cortidelt hostacortin H Di Adreson F Di-Adreson F Di-Adreson-F Di-adreson F DiAdresonF Dicortol Donisolone Dydeltrone EINECS 200-021-7 Eazolin D Econopred Econopred Plus Erbacort Erbasona Estilsona Fernisolone Fernisolone P Fernisolone-P Flamasone Flo-pred HMS1568H10 HMS2090J05 HSDB 3385 Hostacortin H Hydeltra Hydeltra-Tba Hydeltrasol Hydeltrone Hydrodeltalone Hydrodeltisone Hydroretrocortin Hydroretrocortine I-Pred Inflamase Forte Inflamase Mild K 1557 Key-Pred Klismacort LMST02030179 LS-7669 Lentosone Lite Pred M-Predrol MLS001304083 | MLS002154250 MLS002207037 Medrol Medrol Acetate Metacortandralone Methylprednisolone Acetate Meti-Derm Meticortelone Metreton Millipred MolPort-002-507-147 NCGC00179649-01 NSC 9120 NSC9120 NSC9900 Neo-Delta-Cortef Nisolone Nor-Pred T.B.A. Ocu-Pred Ocu-Pred Forte Omnipred Ophtho-Tate Orapred P0152_SIGMA P0637 P6004_SIGMA PRDL PRED-G Panafcortelone Paracortol Paracotol Pediapred Poly-Pred Precortalon Precortancyl Precortilon Precortisyl Pred Forte Pred Mild Predair Predair A Predair Forte Predalone 50 Predalone T.B.A. Predate Predate Tba Predate-50 Predcor-25 Predcor-50 Predcor-Tba Predisolone Sodium Phosphate Predne-Dome Prednelan Predni-Dome Prednicen Predniliderm Predniretard Prednis Prednisolona Prednisolona [INN-Spanish] Prednisolone Prednisolone (JP15/USP/INN) Prednisolone (anhydrous) Prednisolone Acetate Prednisolone Sodium Phosphate Prednisolone Tebutate Prednisolone [INN:BAN:JAN] Prednisolonum Prednisolonum [INN-Latin] Predonin Predonine Prelone Prenolone Prestwick0_000274 Prestwick1_000274 Prestwick2_000274 Prestwick3_000274 Prestwick_404 Rolisone S1737_Selleck SAM002264639 SMR000718761 SPBio_002367 Scherisolon Solone Steran Sterane Sterolone Supercortisol UNII-9PHQ9Y1OLM Ulacort Ultra Pred Ultracorten H Ultracortene H Ultracortene-H Ultracortene-Hydrogen Ultracortene-hydrogen ZINC03833821 component of Ataraxoid component of K-Predne-Dome delta(1)-Cortisol delta(1)-Dehydrocortisol delta(1)-Dehydrohydrocortisone delta(1)-Hydrocortisone delta(sup 1)-Cortisol delta(sup 1)-Dehydrocortisol delta(sup 1)-Dehydrohydrocortisone delta(sup 1)-Hydrocortisone delta-dehydrocortisol delta-dehydrohydrocortisone delta-hydrocortisone prednisolone | |
| | 22 | | Benzocaine | approved | Phase 4, Phase 2, Phase 3 | 1684 | 1994-09-7, 94-09-7 | 2337 | (p-(Ethoxycarbonyl)phenylamine 06952_FLUKA 112909_ALDRICH 112909_SIAL 1333-08-0 20/20 Topical Anesthetic 23239-88-5 23239-88-5 (hydrochloride) 4 Aminobenzoic Acid Ethyl Ester 4-(Ethoxycarbonyl)aniline 4-(Ethoxycarbonyl)phenylamine 4-14-00-01129 (Beilstein Handbook Reference) 4-Aminobenzoate 4-Aminobenzoic acid 4-Aminobenzoic acid ethyl ester 4-Aminobenzoic acid, ethyl ester 4-Carbethoxyaniline 4-amino-benzoic acid ethyl ester 4-aminobenzoic acid ethyl ester 71123-91-6 94-09-7 94-09-7 (Parent) A0271 AB00051923 AC1L1DGC AC1Q341A AC1Q64JE AE-562/40377256 AI3-02081 AKOS000119763 AR-1H9065 Acetate, Benzocaine Aethoform Aethylium paraminobenzoicum Alcohol Prep Pads Allegenal-m Alpha-caine Topical Anesthetic Amben ethyl ester Americaine Anaesthan-syngala Anaesthesin Anaesthesinum Anaesthin Anbesol Jr Anbesol Maximum Strength Anbesol Regular Strength Anestenka Anestezin Anestezin [Russian] Anesthesin Anesthesine Anesthetic Anesthone Atopalm Oral Pain Relief BB_SC-0019 BPBio1_001017 BRD-K75466013-001-05-2 BRN 0638434 BSPBio_000923 BSPBio_001908 Baby Anbesol Baby Anestenka Baby Sensigel Baby Sensigel Night Time Formula Baby Teething Oral Pain Reliever Bactimicina For Sore Throat Bencocaine Topical Anesthetic Bensokain Benz O Sthetic Benzoak Benzocaina Benzocaina [INN-Spanish] Benzocaine Benzocaine (USP/INN) Benzocaine Acetate Benzocaine Formate Benzocaine Hydrobromide Benzocaine Hydrochloride Benzocaine Methanesulfonate Benzocaine [INN:BAN] Benzocainum Benzocainum [INN-Latin] Benzodent Benzoic acid, 4-amino-, ethyl ester Benzoic acid, 4-amino-, ethyl ester, hydrochloride Benzoic acid, amino-, ethyl ester Benzoic acid, p-amino-, ethyl ester Boil Ease Boy Butter Desensitizing Lubricant Boy Butter Extreme Desensitizing Lubricant Boy Butter Extreme H2O Desensitizing Lubricant Brace Relief Budpak Baby Teething Oral Pain Reliever Budpak Oral Maximum Strength C07527 CAS-94-09-7 CHEBI:116735 CHEMBL278172 CID2337 Carmex Cold Sore Treatment External Analgesic Caswell No. 430A Cepacol Fizzlers Cepacol Sensations Hydra Cepacol Sensations Sore Throat Hydra citrus splash Cepacol Sensations Warming Certus Sting Relief Prep Pad Chloraseptic Chloraseptic Warming Sore Throat Colgate Orabase Comfortcaine Topical Anesthetic Cvs Fast Acting Baby Teething Cvs Maximum Strength Cvs Maximum Strength Boil Relief Cvs Oral Anesthetic Cvs Pharmacy Instant Toothache Cvs Pharmacy Maximum Strength Cvs Pharmacy Mouth Sore Gel Cvs Pharmacy Nighttime Oral Pain Relief D001566 D00552 DB01086 Dental Relief Dentek Instant Pain Relief Maximum Strength Dermoplast Diet Ayds DivK1c_000932 Dollar General Toothache Relief Dukal Sting Relief Pad E1501_SIGMA EINECS 202-303-5 EPA Pesticide Chemical Code 097001 ETHYL-P-AMINOBENZOATE Ethoform Ethoforme Ethyl 4-aminobenzoate Ethyl 4-aminobenzoate hydrochloride Ethyl 4-aminobenzoic acid Ethyl Aminobenzoate Ethyl PABA Ethyl aminobenzoate Ethyl aminobenzoate (JP15) Ethyl aminobenzoate (VAN) Ethyl aminobenzoic acid Ethyl p-Aminobenzoate Ethyl p-Aminophenylcarboxylate Ethyl p-aminobenzenecarboxylate Ethyl p-aminobenzoate Ethyl p-aminobenzoic acid Ethyl p-aminophenylcarboxylate Ethylester kyseliny p-aminobenzoove Ethylester kyseliny p-aminobenzoove [Czech] Ethylis aminobenzoas Finafta Baby Finafta MultiOral Formate, Benzocaine Gelato Topical Anesthetic Good Neighbor Pain Relief Goodsense Oral Pain Relief Gps Topical Anesthetic Gumnumb Topical Anesthetic HMS1570O05 HMS1920G09 HMS2091M11 HMS502O14 HSDB 7225 Heb Severe Toothache Herbasoul Male Genital Desensitizer Cream | Hurricaine Hurricaine Topical Anesthetic Hurricaine Topical Anesthetic Gel Hurricaine Topical Anesthetic Liquid Hydrobromide, Benzocaine Hydrochloride, Benzocaine I05-0204 IDI1_000932 Identhesin Insect Bite Relief Instant Toothache Pain Relief Intense Cvs Intense Toothache Iodent Maximum Strength Oral Analgesic Ismile Topical Anesthetic Jianze Sting Relief Pads KBio1_000932 KBio2_000474 KBio2_003042 KBio2_005610 KBio3_001408 KBioGR_000658 KBioSS_000474 Kank-a Mouth Pain Keloform Kmart Smart Sense Kroger Toothache Pain Relief LS-35847 Leader Oral Analgesic Little Colds Sore Throat Relief Melt Aways MLS001331704 MLS002153970 Makesense Junior Pain Relief Makesense Pain Relief Male Desensitizer Pleasure Balm Mandelay Male Genital Desensitizer Mark 3 Methanesulfonate, Benzocaine MolPort-000-871-526 Mouth Sore Medication Mouth Sore Relief Applicator Mouth Sore Relief Professional Strength My Fair Baby Instant Pain Relief NCGC00016352-01 NCGC00094598-01 NCGC00094598-02 NINDS_000932 NSC 122792 NSC 41531 NSC41531 NSC4688 Nene Dente Norcain Norcaine Norcainum Opahl Opahl Dye Free Oprea1_750694 Oprea1_827402 Ora-jel Orabase-B Orajel For All Mouth Sores Maximum Strength Orajel For Cold Sores Orajel For Toothache Maximum Strength Orajel Instant Pain Relief Maximum Strength Orajel Instant Pain Relief Regular Strength Orajel Instant Relief For Teething Pain Orajel Instant Relief For Teething Pain Cooling Cucumber Orajel Instant Relief For Teething Pain Daytime Nighttime Twin Pack Orajel Instant Relief For Teething Pain Longer Lasting Orajel Maximum Strength Orajel Nighttime Instant Relief For Teething Pain Longer Lasting Extra Strength Orajel Severe Toothache Maximum Strength Fast-Acting Formula Oral Analgesic Maximum Strength Oral B Instant Pain Relief Oral Gel Maximum Strength Oral Pain Relief Anesthetic Anesthetic Oral Pain Reliever Oralabs Cold Sore Treatment Orthesin Otocain Outgro Pac-dent Top Gel Pain Relief Pain Relief Alcohol Swabs Parathesin Parathesin (TN) Parathesine Physicians Care Sting Relief Pad Pleasure Balm Kama Sutra Preboost Prestwick0_000712 Prestwick1_000712 Prestwick2_000712 Prestwick3_000712 Prestwick_991 Purelife Topical Anesthetic Quality Choice Maximum Strength Oral Pain Relieving Red Cross Oral Pain Relief Rexall Maximum Strength Rite Aid Baby Care Rite Aid Liquid Anesthetic Oral Pain Relief Rite Aid Maximum Strength Rite Aid Oral Pain Reliever Rite Aid Professional Strength SMR000059025 SPBio_000134 SPBio_002844 SPECTRUM1500139 STK043620 Sally Hansen Ouch-relief Numbing Wipes Sally Hansen Ouch-relief Wax Kit Sally Hansen Ouch-relief Wax Strip Kit Sensigel Severe Oral Pain Reliever Sheffield Baby Teething Gel Sheffield Pain Relief Shunga Male Genital Desensitizer Slim Mint Gum Solarcaine Solu H Spectrum2_000117 Spectrum3_000314 Spectrum4_000249 Spectrum5_000860 Spectrum_000074 Sting Relief Medicated Pad Sting Relief Pads Tanac Terrasil Boil Pain Relief Tiger Supply Inc Topical Anesthetic Top Quality Mfg. Topical Anesthetic Topcaine Topcare Maximum Strength Topical Anesthetic Banana Topical Anesthetic Bubble Gum Topical Anesthetic Cherry Topical Anesthetic Mint Topical Anesthetic Pina Colada Topical Anesthetic Raspberry Topical Anesthetic Strawberry UNII-U3RSY48JW5 Ultracare Anesthetic Bubble Gum Ultracare Anesthetic Butter Rum Ultracare Anesthetic Creme de Menthe Ultracare Anesthetic Pina Colada Ultracare Anesthetic Walterberry WLN: ZR DVO2 Walgreens Baby Teething Walgreens Intense Toothache Walgreens Maximum Strength Walgreens Pain Relieving For Boils Walgreens Severe Oral Pain Reliever Walgreens Severe Toothache Relief Winco Foods Maximum Strength Oral Analgesic ZINC12358719 Zilactin-b benzocaine ethylaminobenzoate-4 h-4-abz-oet nchembio.182-comp4 p-(Ethoxycarbonyl)aniline p-Aminobenzoate p-Aminobenzoic acid p-Aminobenzoic acid ethyl ester p-Aminobenzoic acid, ethyl ester p-Aminobenzoic ethyl ester p-Carbethoxyaniline p-Ethoxycarboxylic Aniline p-Ethoxycarboxylic aniline |
| | 23 | | Neomycin | approved | Phase 4 | 42 | 1404-04-2 | 8378 | (1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol 11025-81-3 119-04-0 1393-86-8 1404-04-2 1405-10-3 (sulfate (salt)) 4-18-00-07476 (Beilstein Handbook Reference) 72131_FLUKA AB00443887 AC1L1QVH Actilin Actiline Antibiotic 10676 Antibiotic produced by Streptomyces decaris. Neomycin B Antibiotique BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG BDG-(1-4)NEB-(5-1)RIB-(3-1)NED BPBio1_000326 BRN 0101621 BSPBio_000296 C01737 C23H46N6O13 C25H50N6O13 CCRIS 5462 CHEBI:7508 CID8378 Caswell No. 595 D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy D05140 DB00452 DB00994 EINECS 204-292-2 EINECS 215-766-3 EPA Pesticide Chemical Code 006303 Endomixin Enterfram Fradiomycin Fradiomycin B Fradiomycinum Framicetina Framicetina [INN-Spanish] Framycetin Framycetin (INN) Framycetin [INN:BAN:DCF] Framycetine Framycetine [INN-French] Framycetinum Framycetinum [INN-Latin] Framygen | Fraquinol HMS2089P15 HSDB 3242 LS-96091 LS-96095 MolPort-003-938-736 Myacine Myacyne Mycifradin Myciguent N1142_SIGMA NCGC00179612-01 NEOMYCIN AND POLYMYXIN B SULFATES NEOMYCIN B NEOMYCIN SULFATE NMY Neo-Fradin Neo-Rx Neo-fradin Neobiotic Neobrettin Neolate Neomas Neomcin Neomicina Neomicina [DCIT] Neomin Neomycin B Sulfate Neomycin B sulfate Neomycin Sulfate Neomycin Sulphate Neomycin solution Neomycine Neomycine [INN-French] Neomycinum Neomycinum [INN-Latin] Nivemycin PIMAVECORT Prestwick3_000158 ST075177 Soframycin Soframycin Ophthalmic Soframycine Theraplusplus Plus Tuttomycin UNII-4BOC774388 UNII-I16QD7X297 USAF CB-19 VONAMYCIN Vonamycin powder V neomycin | |
| | 24 | | Chlorhexidine | approved | Phase 4 | 392 | 55-56-1 | 9552079, 2713 | 1,1 inverted exclamation marka-Hexamethylenebis[5-(4-chlorophenyl)biguanide] 1,1'-Hexamethylene bis(5-(P-chlorophenyl)biguanide) 1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide) 1,1'-Hexamethylenebis(5-(p-chlorophenyl)biguanide) 1,1'-Hexamethylenebis[5-(4-chlorophenyl)biguanide 1,6-Bis(5-(p-chlorophenyl)biguandino)hexane 1,6-Bis(p-chlorophenyldiguanido)hexane 1,6-Di(4'-chlorophenyldiguanido)hexane 1,6-Di(N-p-chlorophenyldiguanido)hexane 24798_FLUKA 282227_ALDRICH 348031_ALDRICH 4-12-00-01201 (Beilstein Handbook Reference) 55-56-1 AB00053427 AB1003159 AVAGARD BPBio1_000272 BRN 2826432 BSPBio_000246 BSPBio_001977 Betasept C06902 C22H30Cl2N10 CAS-55-56-1 CCRIS 9230 CHEBI:3614 CHEMBL790 CID9552079 Chlorhexidin Chlorhexidin [Czech] Chlorhexidine Chlorhexidine (INN) Chlorhexidine Base Chlorhexidine Gluconate Chlorhexidine [INN:BAN] Chlorhexidine gluconate Chlorhexidinum Chlorhexidinum [INN-Latin] Cloresidina Cloresidina [DCIT] Clorhexidina Clorhexidina [INN-Spanish] D07668 DB00878 Decanoylacetaldehyde Sodium Sulfide Dentisept [veterinary] Dentisept [veterinary] (TN) DivK1c_000761 EINECS 200-238-7 Fimeil HMS1568M08 HSDB 7196 Hexadol Hibiclens Hibispray Hibistat I06-0621 I14-0050 IDI1_000761 KBio1_000761 | KBio2_000717 KBio2_003285 KBio2_005853 KBio3_001197 KBioGR_000774 KBioSS_000717 LS-43917 Lisium (*Dihydrochloride*) MK-412A MLS001332387 MLS001332388 MLS002154209 Merfen-incolore Merfen-incolore (TN) MolPort-002-541-741 N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)] N,N''''-hexane-1,6-diylbis[N'-(4-chlorophenyl)(imidodicarbonimidic diamide)] N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradeca- nediimidamide N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide NCGC00016246-01 NCGC00091025-01 NCGC00091025-02 NINDS_000761 NSC526936 Nolvasan Nolvasan (*Diacetate*) Novalsan Oro-Clense Paroex Perichlor Peridex Periochip Periogard Prestwick0_000143 Prestwick1_000143 Prestwick2_000143 Prestwick3_000143 Prestwick_53 QTL1_000020 Rotersept SMR000857146 SPBio_000210 SPBio_002185 STK089248 STOCK1S-18831 Savloclens Savlon babycare Sebidin A Sodium Houttuyfonamide Soretol Spectrum2_000135 Spectrum3_000339 Spectrum4_000277 Spectrum5_001322 Spectrum_000237 Sterido Sterilon Superspray Tubulicid UNII-R4KO0DY52L chlorhexidine | |
| | 25 | | Ergocalciferol | approved, nutraceutical | Phase 4 | 923 | 50-14-6 | 5280793 | 'Ergosterol irradiated' (+)-Vitamin D2 (3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol (3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol (3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol (3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol (3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol (3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol (5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol (5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol (5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol (5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol (5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol 22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol 31316-19-5 4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol 47768_SUPELCO 50-14-6 7489-18-1 7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87 8017-28-5 9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol 9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol 9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol 9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol 95220_FLUKA 95220_SIGMA AC-1355 AC1L1FIE AC1NQXLH AC1NS4DE AC1NS9GI AC1NSSVD AC1NWAM3 AC1O5EDK AC1O6WAM ACon1_002187 Activated ergosterol BPBio1_000418 BSPBio_000380 BSPBio_001974 Buco-D C05441 C28H44O CALCIFEROL IN A GELATIN MATRIX CALCIFEROL, U.S.P. CHEBI:28934 CHEMBL1536 CID11003810 CID3249 CID5280793 CID5315257 CID5353610 CID5356615 CID5702050 CID6432478 CID6536972 Calciferol Calciferol (TN) Calciferol (vitamin D2) Calciferolum Calciferon 2 Condacaps Condocaps Condol Crtron Crystallina D-Arthin D-Tracetten D00187 DB00153 Daral Davitamon D Davitin De-rat concentrate Decaps Dee-Osterol Dee-Ron Dee-Ronal Dee-Roual Deltalin Deratol Detalup Diactol Divit urto Doral Drisdol Drisdol (TN) E5750_SIGMA EINECS 200-014-9 Ercalciol Ergocalciferol Ergocalciferol (D2) Ergocalciferol (JP15/USP) Ergocalciferol [INN:BAN:JAN] Ergocalciferol oil Ergocalciferol: Vitamin D | Ergocalciferolo Ergocalciferolo [DCIT] Ergocalciferols Ergocalciferolum Ergocalciferolum [INN-Latin] Ergorone Ergosterol activated Ergosterol irradiated Ergosterol, irradiated Ertron Fortodyl Geltabs Geltabs Vitamin D HMS1920K20 HMS2091B19 HMS502I07 HSDB 819 Haliver Hi-Deratol Hyperkil I05-0022 IDI1_000805 Infron Irradiated ergosta-5,7,22-trien-3-beta-ol Irradiated ergosta-5,7,22-trien-3.beta.-ol Irradiated ergosta-5,7,22-trien-3beta-ol Irradiated ergosterol LMST03010001 LMST03010014 LS-3228 MEGxm0_000466 MLS001332467 MLS001332468 Metadee Mina D2 MolPort-001-740-057 MolPort-001-793-930 MolPort-002-526-645 MolPort-003-666-178 MolPort-006-822-629 Mulsiferol Mykostin NCGC00142497-01 NCGC00179579-01 NCGC00179579-02 NSC 62792 NSC62792 Novovitamin-D Oleovitamin D Oleovitamin D, Synthetic Oleovitamin D2 Osteil Ostelin Prestwick3_000420 Prestwick_554 Radiostol Radstein Radsterin Rodine C Rodinec SMR000857106 SPECTRUM1500276 ST057150 STOCK1N-53397 Shock-ferol Shock-ferol sterogyl Sorex C.R Sorex C.R. Spectrum5_000666 Sterogyl Synthetic Vitamin D UNII-VS041H42XC Uvesterol D Uvesterol-D VITAMIN D2 VITAMIN D2 WATER DISPERSABLE U.S.P. VITAMIN_D2 Vigantol Vio D Vio-D Viostdrol Viosterol Viosterol in Oil Vitamin D Vitamin D2 Vitamin- D2 Vitamin-?D2 Vitamina D2 Vitavel-D WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ ZINC04474571 ZINC04629876 beta-Ol bmse000510 component of Geltabs Vitamin D delta-Arthin delta-Tracetten ergocalciferol vitamin d-2 |
| | 26 | | Vitamin E | approved, nutraceutical | Phase 4 | 371 | 59-02-9 | 14985 | (+)-a-Tocopherol (+)-alpha-Tocopherol (+)-alpha-tocopherol (+)-α-tocopherol (2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-ol (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol (2R,4'R,8'R)-a-Tocopherol (2R,4'R,8'R)-alpha-Tocopherol (2R,4'R,8'r)-alpha-tocopherol (R,R,R)-a-Tocopherol (R,R,R)-alpha-Tocopherol (R,R,R)-alpha-tocopherol (R,R,R)-α-tocopherol 5,7,8-Trimethyltocol Amino-Opti-E Aquasol E D-alpha-Tocopherol Daltose Denamone E-200 I.U. Softgels | E-Complex-600 E-Ferol E-Vitamin succinate Eprolin Gordo-Vite E Phytogermin Phytogermine RRR-alpha-tocopherol RRR-alpha-tocopheryl Tocopherol Vitamin E Vitamin Ea Vitamin Plus E Softgells Vitamin e Vitec a-D-Tocopherol a-Tocopherol alpha-Tocopherol alpha-delta-Tocopherol d-alpha-tocopherol d-α-tocopherol delta-alpha-Tocopherol |
| | 27 | | Cholecalciferol | approved, nutraceutical | Phase 4 | 799 | 67-97-0 | 6221, 10883523, 5280795 | ()-Vitamin D3 (+)-Vitamin D3 (+)-vitamin D3 (1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol (3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol (3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol (3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol (3beta,Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol (5E,7E)-9,10-Secocholesta-5,7,10-trien-3-ol (5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol (5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol (5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol 1406-16-2 25(OH)D 3-beta,Z,7E-9,10-Secocholestr-5,7,10(19)-trien-3-ol 47763_SUPELCO 57651-82-8 67-97-0 7-Dehydrocholesterol activated 7-Dehydrocholesterol, Activated 7-Dehydrocholesterol, irradiated 7-Dehydrocholestrol, activated 8024-19-9 8050-67-7 89193_FLUKA 9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol 9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol 9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol 9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol 9,10-Secocholesta-5,7,10(19)-trien-3-ol 9,10-Secocholesta-5,7,10-trien-3-ol AB1002422 AC-11697 AC1L1ECK AC1L1M23 AC1LU7IZ AC1NQXLN AC1NR2UO AC1NR2UR AC1NR2UU AC1NS4AJ AC1NSHJX AC1O5EOF AC1O7GAV AC1O7GQ3 AC1O8FEU AC1O8PWJ AC1OF2GI AC1OF2GL AC1OIEW5 AC1OIEWB ACon1_001997 Activated 7-dehydrocholesterol Arachitol BPBio1_000460 BSPBio_000418 BSPBio_002408 Bio-0845 C05443 C1357_SIAL C27H44O C9756_SIGMA C9774_SIAL CAS-67-97-0 CC CCRIS 5813 CCRIS 6286 CHEBI:283119 CHEBI:28940 CHEMBL1042 CHEMBL432780 CID10000117 CID10045875 CID10340013 CID10883523 CID10894379 CID11014566 CID11025493 CID11058152 CID11463269 CID1548921 CID2735 CID5280795 CID5283710 CID5283711 CID5283712 CID5353527 CID5363362 CID6221 CID6432644 CID6604201 CID6604662 CID6708595 CID6713938 CID6992015 CID6992016 CID7067439 CID7067440 CID7251172 CID7251174 CID9821465 Calciol Cholecalciferol Cholecalciferol (D3) Cholecalciferol (JP15/USP) Cholecalciferol D3 Cholecalciferol [USAN:BAN:JAN] Cholecalciferol, D3 Cholecalciferolum | Colecalciferol Colecalciferol (INN) Colecalciferolo Colecalciferolo [DCIT] Colecalciferolum Colecalciferolum [INN-Latin] Colecalcipherol D00188 D3-Vicotrat D3-Vigantol DB00169 Delsterol Delta-D Delta-D (TN) Deparal Devaron DivK1c_006276 Duphafral D3 1000 EINECS 200-673-2 EINECS 215-797-2 EPA Pesticide Chemical Code 202901 Ebivit FeraCol Granuvit D3 HMS1569E20 HMS2092M12 HSDB 820 I05-0041 Irradiated 7-dehydrocholesterol KBio1_001220 KBio2_001643 KBio2_004211 KBio2_006779 KBio3_001628 KBioGR_001602 KBioSS_001643 LMST03020001 LMST03020219 LMST03020220 LMST03020221 LS-1570 LS-825 LT00244775 MEGxm0_000458 Micro-dee MolPort-001-740-051 MolPort-001-785-972 MolPort-003-666-021 MolPort-004-946-964 NCGC00016301-01 NCGC00017328-01 NCGC00091072-01 NCGC00142511-01 NCGC00159331-02 NCGC00159331-04 NCGC00178668-01 NCGC00179565-01 NCGC00179565-02 NEO Dohyfral D3 NSC 375571 NSC-375571 NSC375571 Oleovitamin D3 Prestwick0_000429 Prestwick1_000429 Prestwick2_000429 Prestwick3_000429 Prestwick_63 Provitamine Provitina Quintox Rampage Ricketon SMP1_000068 SPBio_001298 SPBio_002357 SR-05000001559 SR-05000001559-3 ST057172 SpecPlus_000180 Spectrum2_001369 Spectrum3_000764 Spectrum4_001201 Spectrum_001163 TNP00266 Trivitan UNII-1C6V77QF41 UPCMLD-DP152 UPCMLD-DP152:001 VITAMIN D VITAMIN D3 POWDER VITAMIN_D3 Vi-De3 Vi-de-3-hydrosol VidDe-3-hydrosol Videkhol Vigantol Vigorsan Vitamin D3 Vitamin D3 emulsifiable Vitinc Dan-Dee-3 ZINC04474460 ZINC04492874 ZINC04492875 ZINC04492876 ZINC04492878 bmse000507 calciol cholecalciferol delta-D vitamin d-3 |
| | 28 | | Maleic acid | experimental | Phase 4, Phase 1 | 274 | 110-16-7 | 444972, 444266 | (2Z)-2-Butenedioate (2Z)-2-Butenedioic acid (2Z)-Butene-2-dioate (2Z)-Butene-2-dioic acid (2Z)-but-2-enedioate (2Z)-but-2-enedioic acid (Z)-2-Butenedioate (Z)-2-Butenedioic acid (z)-butenedioate (z)-butenedioic acid 2-Butenedioate 2-Butenedioic acid Cis-butenedioate Cis-butenedioic acid | H2male Kyselina maleinova MAE Maleate Maleic acid Maleic acid [NA2215] Maleinic acid Malenic acid Malezid CM Scotchbond multipurpose etchant Toxilic acid cis-1,2-Ethylenedicarboxylic acid cis-2-Butenedioate cis-2-Butenedioic acid cis-But-2-enedioate cis-But-2-enedioic acid |
| | 29 | | Adefovir | | Phase 4, Phase 3, Phase 2, Phase 1 | 130 | | | | 30 | | Anti-Retroviral Agents | | Phase 4, Phase 3, Phase 2, Phase 1 | 2794 | | | | 31 | | Antiviral Agents | | Phase 4, Phase 3, Phase 2, Phase 1 | 8071 | | | | 32 | | Nucleic Acid Synthesis Inhibitors | | Phase 4, Phase 3, Phase 2, Phase 1 | 3836 | | | | 33 | | Reverse Transcriptase Inhibitors | | Phase 4, Phase 3, Phase 2, Phase 1 | 1656 | | | | 34 | | Anti-Infective Agents | | Phase 4, Phase 3, Phase 2, Phase 1 | 17220 | | | | 35 | | Calcium, Dietary | | Phase 4, Phase 1, Phase 2 | 4678 | | | | 36 | | Hydroxymethylglutaryl-CoA Reductase Inhibitors | | Phase 4, Phase 1 | 1804 | | | | 37 | | Polyene phosphatidylcholine | | Phase 4, Phase 1, Phase 2 | 5 | | | | 38 | | Vitamins | | Phase 4, Phase 3, Phase 2 | 3857 | | | | 39 | | Anticholesteremic Agents | | Phase 4, Phase 1 | 1732 | | | | 40 | | Antibodies | | Phase 4, Phase 3, Phase 1, Phase 2 | 4477 | | | | 41 | | Anti-Bacterial Agents | | Phase 4, Phase 2 | 9140 | | | | 42 | | Antirheumatic Agents | | Phase 4, Phase 2 | 8496 | | | | 43 | | Bone Density Conservation Agents | | Phase 4, Phase 1 | 2600 | | | | 44 | | Hypolipidemic Agents | | Phase 4, Phase 1, Phase 2 | 2228 | | | | 45 | | Heptavalent Pneumococcal Conjugate Vaccine | | Phase 4, Phase 3, Phase 2 | 440 | | | | 46 | | Hepatitis A Antibodies | | Phase 4, Phase 3 | 9 | | | | 47 | | | | Phase 4 | | | | | 48 | | Cytochrome P-450 CYP2C9 Inhibitors | | Phase 4 | 497 | | | | 49 | | Antimetabolites | | Phase 4, Phase 3, Phase 2, Phase 1 | 9454 | | | | 50 | | Hepatitis B Antibodies | | Phase 4, Phase 3, Phase 2 | 10 | | |
Interventional clinical trials: (show top 50)
(show all 776)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection | Completed | NCT00127959 | Phase 4 | | 2 | A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays | Completed | NCT01098006 | Phase 4 | | 3 | Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection | Completed | NCT00662545 | Phase 4 | | 4 | Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection | Completed | NCT00371150 | Phase 4 | | 5 | A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection | Completed | NCT00736190 | Phase 4 | | 6 | A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection | Completed | NCT00393484 | Phase 4 | | 7 | Tenofovir in HIV/HBV Coinfection | Completed | NCT00192595 | Phase 4 | | 8 | Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025 | Completed | NCT00142740 | Phase 4 | | 9 | Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth | Completed | NCT00106964 | Phase 4 | | 10 | Hepatitis B Vaccination Through Syringe Exchange Programs: A Randomized, Controlled Trial of Vaccination Schedules | Completed | NCT01259453 | Phase 4 | | 11 | Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B Virus | Completed | NCT01788371 | Phase 4 | | 12 | Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients | Completed | NCT02108444 | Phase 4 | | 13 | Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination | Completed | NCT01357720 | Phase 4 | | 14 | Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ Mothers | Completed | NCT00240500 | Phase 4 | | 15 | Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg) | Completed | NCT00240539 | Phase 4 | | 16 | LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers | Completed | NCT00240526 | Phase 4 | | 17 | Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™ | Completed | NCT00875485 | Phase 4 | | 18 | Hepatitis B Vaccination in HIV-infected Persons | Completed | NCT00230061 | Phase 4 | | 19 | Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents | Completed | NCT00141999 | Phase 4 | | 20 | Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients | Completed | NCT00186836 | Phase 4 | | 21 | Randomized Controlled Trial of Tenofovir in Patients of Reactivation of Hepatitis B Presenting as Acute on Chronic Liver Failure | Completed | NCT01074645 | Phase 4 | | 22 | Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc | Completed | NCT00289731 | Phase 4 | | 23 | Long-Term Lamivudine Therapy for Chronic Hepatitis B | Completed | NCT00120354 | Phase 4 | | 24 | Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B | Completed | NCT00926757 | Phase 4 | | 25 | Qidong Hepatitis B Intervention Study | Completed | NCT00222664 | Phase 4 | | 26 | Efficacy Optimizing Research of Lamivudine Therapy | Completed | NCT01088009 | Phase 4 | | 27 | EFFicacy Optimization Research of Telbivudine Therapy | Completed | NCT00962533 | Phase 4 | | 28 | Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B | Completed | NCT00877760 | Phase 4 | | 29 | Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (PEG) Versus TDF or PEG Monotherapy in Chronic Hepatitis B | Completed | NCT01277601 | Phase 4 | | 30 | Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine | Completed | NCT00674908 | Phase 4 | | 31 | Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine | Completed | NCT00617812 | Phase 4 | | 32 | A Study of Peginterferon Alfa-2a (Pegasys) in Participants With Hepatitis B E-Antigen (HBeAg)-Positive Chronic Hepatitis B Virus (HBV) | Completed | NCT02604823 | Phase 4 | | 33 | A Study to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B | Completed | NCT02598063 | Phase 4 | | 34 | A Study of PEGASYS (Peginterferon Alfa-2a [40KD]) in Patients With Hepatitis B e Antigen (HBeAg)-Negative Chronic Hepatitis B Virus (HBV) | Completed | NCT02570191 | Phase 4 | | 35 | Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine | Completed | NCT02445703 | Phase 4 | | 36 | Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects | Completed | NCT02202473 | Phase 4 | | 37 | This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the Immunogenicity and Safety of Hepatitis B Vaccine in Adolescents Vaccinated in Infancy With Infanrix™ Hexa | Completed | NCT02052661 | Phase 4 | | 38 | A Control Study to Evaluate The Efficacy And Safety of Ozone-therapy in Chronic Hepatitis B | Completed | NCT01887275 | Phase 4 | | 39 | Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder | Completed | NCT01847430 | Phase 4 | | 40 | An Expanded Access Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Negative Chronic Hepatitis B | Completed | NCT01787279 | Phase 4 | | 41 | Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B | Completed | NCT01743079 | Phase 4 | | 42 | Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Alfa-2b Treatment to Increase Sustained Response in HBeAg-positive Chronic Hepatitis B | Completed | NCT01532843 | Phase 4 | | 43 | A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B. | Completed | NCT01519921 | Phase 4 | | 44 | Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept | Completed | NCT01379508 | Phase 4 | | 45 | Efficacy, Safety and Tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women With Elevated Alanine Aminotransferase Levels | Completed | NCT01337791 | Phase 4 | | 46 | Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children | Completed | NCT01333813 | Phase 4 | | 47 | A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis | Completed | NCT01264367 | Phase 4 | | 48 | An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B | Completed | NCT01264354 | Phase 4 | | 49 | An Open Study to Evaluate the Sustained Effect in Patients Showing Virological Responses With Muscle-related Symptom of Chronic Hepatitis B Patients Who Received Clevudine | Completed | NCT01264107 | Phase 4 | | 50 | An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB) | Completed | NCT01205165 | Phase 4 |
|
